Equities

Guangzhou Jet Bio-Filtration Co Ltd

688026:SHH

Guangzhou Jet Bio-Filtration Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)14.51
  • Today's Change-0.12 / -0.82%
  • Shares traded2.17m
  • 1 Year change-20.58%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments365310263
Total Receivables, Net142112144
Total Inventory84125123
Prepaid expenses5.341339
Other current assets, total1742890.52
Total current assets771849570
Property, plant & equipment, net550627557
Goodwill, net0----
Intangibles, net545912
Long term investments2456231
Note receivable - long term------
Other long term assets------
Total assets1,6261,6051,180
LIABILITIES
Accounts payable396467
Accrued expenses151722
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.856.518.51
Other current liabilities, total463446
Total current liabilities103121144
Total long term debt33731530
Total debt34032239
Deferred income tax0.041.801.96
Minority interest0.620.73--
Other liabilities, total282732
Total liabilities469466209
SHAREHOLDERS EQUITY
Common stock140140100
Additional paid-in capital414421452
Retained earnings (accumulated deficit)473448420
Treasury stock - common------
Unrealized gain (loss)0.600.22--
Other equity, total130130--
Total equity1,1571,139972
Total liabilities & shareholders' equity1,6261,6051,180
Total common shares outstanding140140140
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.